On 9 December 2021 Memphasys announced the clinical trial with Monash IVF. Completion date was to be in December 2022. This date has now blown out to fourth quarter 2024. India and and other international sales appear to be dependent on TGA approval in Australia. TGA approval dependent on the Monash trial. TGA approval date is now Quarter 3 2025. I think the design of study is at fault for the two year plus blow out in timelines and needs to be reviewed to allow quicker results and at least an application for TGA approval. Samson was a dud and everything now seems to be dependent on Japaneses sales of Felix. There was a time I was buying every time the share price dropped below .10c. Currently 81% down, so definitely holding for the long term and will use any capital raises to top up and support the company.
The science and technology appears to be sound and my best chance of realising profits is for the company to succeed.
On 9 December 2021 Memphasys announced the clinical trial with...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MEM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $9.679M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.7¢ | $24.90K | 3.121M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 8200599 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1008418 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| MEM (ASX) Chart |